Single-cell RNA Sequencing Reveals Small Extracellular Vesicles Derived from Malignant Cells That Contribute to Angiogenesis in Human Breast Cancers

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2023 Aug 25

PMID 37626402

Authors

Youxue Zhang

Fang Zhen

Yue Sun

Bing Han

Hongyi Wang

Yuhang Zhang

Huaixi Zhang

Jing Hu

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is the most common cancer affecting women across the world. Tumor endothelial cells (TECs) and malignant cells are the major constituents of the tumor microenvironment (TME), but their origin and role in shaping disease initiation, progression, and treatment responses remain unclear due to significant heterogeneity.

Methods: Tissue samples were collected from eight patients presenting with breast cancer. Single-cell RNA sequencing (scRNA-seq) analysis was employed to investigate the presence of distinct cell subsets in the tumor microenvironment. InferCNV was used to identify cancer cells. Pseudotime trajectory analysis revealed the dynamic process of breast cancer angiogenesis. We validated the function of small extracellular vesicles (sEVs)-derived protein phosphatase 1 regulatory inhibitor subunit 1B (PPP1R1B) in vitro experiments.

Results: We performed single-cell transcriptomics analysis of the factors associated with breast cancer angiogenesis and identified twelve subclusters of endothelial cells involved in the tumor microenvironment. We also identified the role of TECs in tumor angiogenesis and confirmed their participation in different stages of angiogenesis, including communication with other cell types via sEVs. Overall, the research uncovered the TECs heterogeneity and the expression levels of genes at different stages of tumor angiogenesis.

Conclusions: This study showed sEVs derived from breast cancer malignant cells promote blood vessel formation by activating endothelial cells through the transfer of PPP1R1B. This provides a new direction for the development of anti-angiogenic therapies for human breast cancer.

Citing Articles

Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling.

Regner M, Garcia-Recio S, Thennavan A, Wisniewska K, Mendez-Giraldez R, Felsheim B Cell Genom. 2025; 5(2):100765.

PMID: 39914387 PMC: 11872555. DOI: 10.1016/j.xgen.2025.100765.

Protein serine/threonine phosphatases in tumor microenvironment: a vital player and a promising therapeutic target.

Liu Y, Xia F, Zhu C, Song J, Tang B, Zhang B Theranostics. 2025; 15(3):1164-1184.

PMID: 39776803 PMC: 11700861. DOI: 10.7150/thno.104529.

Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations.

Miceli R, Chen T, Nose Y, Tichkule S, Brown B, Fullard J J Extracell Vesicles. 2024; 13(12):e70005.

PMID: 39625409 PMC: 11613500. DOI: 10.1002/jev2.70005.

The development of the occurrence and metastasis of breast cancer by single-cell sequencing.

Chen M, Feng M, Lei H, Mo D, Ren S, Yang D Cancer Cell Int. 2024; 24(1):349.

PMID: 39462368 PMC: 11515250. DOI: 10.1186/s12935-024-03531-x.

Identification of new subtypes of breast cancer based on vasculogenic mimicry related genes and a new model for predicting the prognosis of breast cancer.

Liang X, Ma X, Luan F, Gong J, Zhao S, Pan Y Heliyon. 2024; 10(17):e36565.

PMID: 39263085 PMC: 11387377. DOI: 10.1016/j.heliyon.2024.e36565.

References

Natale G, Bocci G, Lenzi P . Looking for the Word "Angiogenesis" in the History of Health Sciences: From Ancient Times to the First Decades of the Twentieth Century. World J Surg. 2016; 41(6):1625-1634. DOI: 10.1007/s00268-016-3680-1. View

Betz C, Lenard A, Belting H, Affolter M . Cell behaviors and dynamics during angiogenesis. Development. 2016; 143(13):2249-60. DOI: 10.1242/dev.135616. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Wang Y, Minden A . Current Molecular Combination Therapies Used for the Treatment of Breast Cancer. Int J Mol Sci. 2022; 23(19). PMC: 9569555. DOI: 10.3390/ijms231911046. View

Bareschino M, Schettino C, Colantuoni G, Rossi E, Rossi A, Maione P . The role of antiangiogenetic agents in the treatment of breast cancer. Curr Med Chem. 2011; 18(33):5022-32. DOI: 10.2174/092986711797636072. View

Saad E, Katz A, Buyse M . Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials. J Clin Oncol. 2010; 28(11):1958-62. DOI: 10.1200/JCO.2009.25.5414. View

Uzzan B, Nicolas P, Cucherat M, Perret G . Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res. 2004; 64(9):2941-55. DOI: 10.1158/0008-5472.can-03-1957. View

Bielenberg D, Zetter B . The Contribution of Angiogenesis to the Process of Metastasis. Cancer J. 2015; 21(4):267-73. PMC: 4670555. DOI: 10.1097/PPO.0000000000000138. View

10.

Carmeliet P, Jain R . Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011; 473(7347):298-307. PMC: 4049445. DOI: 10.1038/nature10144. View

11.

Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D . Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther. 2020; 5(1):242. PMC: 7572387. DOI: 10.1038/s41392-020-00359-5. View

12.

Hu W, Liu C, Bi Z, Zhou Q, Zhang H, Li L . Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Mol Cancer. 2020; 19(1):102. PMC: 7273667. DOI: 10.1186/s12943-020-01199-1. View

13.

Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y . Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. Clin Transl Med. 2022; 12(2):e730. PMC: 8858624. DOI: 10.1002/ctm2.730. View

14.

Hafemeister C, Satija R . Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019; 20(1):296. PMC: 6927181. DOI: 10.1186/s13059-019-1874-1. View

15.

Patel A, Tirosh I, Trombetta J, Shalek A, Gillespie S, Wakimoto H . Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014; 344(6190):1396-401. PMC: 4123637. DOI: 10.1126/science.1254257. View

16.

Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M . The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014; 32(4):381-386. PMC: 4122333. DOI: 10.1038/nbt.2859. View

17.

Aibar S, Gonzalez-Blas C, Moerman T, Huynh-Thu V, Imrichova H, Hulselmans G . SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017; 14(11):1083-1086. PMC: 5937676. DOI: 10.1038/nmeth.4463. View

18.

Hu J, Yang D, Zhang H, Liu W, Zhao Y, Lu H . USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma. Lung Cancer. 2015; 88(3):239-45. DOI: 10.1016/j.lungcan.2015.02.019. View

19.

Tian Y, Gong M, Hu Y, Liu H, Zhang W, Zhang M . Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2019; 9(1):1697028. PMC: 6896440. DOI: 10.1080/20013078.2019.1697028. View

20.

Thery C, Witwer K, Aikawa E, Alcaraz M, Anderson J, Andriantsitohaina R . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2019; 7(1):1535750. PMC: 6322352. DOI: 10.1080/20013078.2018.1535750. View